PharmaCyte Biotech (PMCB) Accumulated Expenses (2011 - 2026)
PharmaCyte Biotech's Accumulated Expenses came in at $345,656 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 42.0% from $595,656 a year earlier and down 33.9% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Accumulated Expenses was $522,831, down 79.4% from FY2025.
- Accumulated Expenses carries a five-year compound annual growth rate of -1.1% (FY2021 to FY2026).
- Going back by fiscal year, Accumulated Expenses was $2.54 million in FY2025 (+245.5%), $735,199 in FY2024 (+60.4%), $458,300 in FY2023 (-8.2%) and $499,009 in FY2022 (-9.7%).
- The fiscal Q1 2027 figure represents the lowest quarterly Accumulated Expenses since fiscal Q2 2022.
- Year-over-year, Accumulated Expenses has declined for five consecutive quarters, with growth averaging 1.1% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in fiscal Q4 2025 (growth of 245.5%), and the weakest in fiscal Q2 2022 (a decline of 94.3%).
- Business Quant data shows PMCB's Accumulated Expenses at $522,831 (Q4 2026), $445,656 (Q3 2026) and $520,656 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 345,656.00 |
| Apr 30, 2026 | 522,831.00 |
| Jan 31, 2026 | 445,656.00 |
| Oct 31, 2025 | 520,656.00 |
| Jul 31, 2025 | 595,656.00 |
| Apr 30, 2025 | 2.54 Mn |
| Jan 31, 2025 | 709,436.00 |
| Oct 31, 2024 | 707,185.00 |
| Jul 31, 2024 | 684,136.00 |
| Apr 30, 2024 | 735,199.00 |
| Jan 31, 2024 | 774,439.00 |
| Oct 31, 2023 | 1.02 Mn |
| Jul 31, 2023 | 480,036.00 |
| Apr 30, 2023 | 458,300.00 |
| Jan 31, 2023 | 381,899.00 |
| Oct 31, 2022 | 449,855.00 |
| Jul 31, 2022 | 530,331.00 |
| Apr 30, 2022 | 499,009.00 |
| Jan 31, 2022 | 520,115.00 |
| Oct 31, 2021 | 29,083.00 |
API Access
PharmaCyte Biotech Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();